“…However, such efforts are labor intensive (Haruyama et al, 2009), and gene delivery by comparison is more rapid and offers translational opportunities (Kotterman and Schaffer, 2014). Prior work in the field established some transduction of neural progenitors, but efficiency was limited and did not include Type 1 NSCs (Falk et al, 2002;Lemkine et al, 2002;van Hooijdonk et al, 2009). AAV vectors have gathered increasing momentum for basic biological investigation (Oh et al, 2014) and for clinical gene delivery (Bainbridge et al, 2008;Kotterman and Schaffer, 2014;MacLaren et al, 2014;Maguire et al, 2008Maguire et al, , 2009Nathwani et al, 2011;Ojala et al, 2015).…”